Point72 Asia (Singapore) Pte. Ltd. Alx Oncology Holdings Inc Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $532 Billion
- Q3 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 9,369 shares of ALXO stock, worth $15,552. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,369Holding current value
$15,552% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ALXO
# of Institutions
101Shares Held
39.7MCall Options Held
134KPut Options Held
17.4K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$16.1 Million14.51% of portfolio
-
Tang Capital Management LLC San Diego, CA4.2MShares$6.98 Million0.65% of portfolio
-
Vivo Capital, LLC Palo Alto, CA4.03MShares$6.7 Million1.07% of portfolio
-
Redmile Group, LLC San Francisco, CA3.84MShares$6.37 Million0.46% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$4.46 Million0.0% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $67.6M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...